Key Highlights
- Ravi Parthasarathy appointed as CTO of Diality, previously VP at ICU Medical.
- Parthasarathy boasts a rich background in device engineering from companies like Baxter Healthcare and Siemens Medical Systems.
- Clayton Poppe to take on role as Chief Scientific Officer, focusing on research and regulatory functions.
Source: Business Wire
Notable Quotes
- “We are delighted to welcome someone of Ravi’s expertise and passion to Diality. Ravi’s wealth of experience leading development of innovative products and his alignment with Diality’s mission, vision, and values,” – Osman Khawar, M.D., CEO at Diality
- “Diality’s mission of improving lives impacted by kidney disease resonates very strongly with me,” – Ravi Parthasarathy, Chief Technology Officer at Diality
SoHC's Take
The strategic hire of Ravi Parthasarathy signifies Diality’s commitment to innovation in the field of hemodialysis. His extensive background in product development and leadership, particularly in medical devices, is set to propel Diality’s Moda-flxTM Hemodialysis System development forward. This move not only enhances Diality’s technological advancements but also underscores their dedication to improving patient care in the realm of kidney disease. As Diality continues to navigate the pre-approval phase of their hemodialysis system, the expertise of seasoned leaders like Parthasarathy and Poppe will be pivotal in meeting both clinical and regulatory milestones.
